New treatment offers hope for multiple myeloma and lymphoma
Karyopharm of Israel and Massachusetts gets FDA approval for XPOVIO, the first drug aimed to help natural tumor-suppressing proteins do their job.
OCTOBER 7, 2019, 8:00 AM
Brian has been a journalist and high-tech entrepreneur for over 20 years. He combines this expertise for ISRAEL21c as he writes about hot new local startups, pharmaceutical advances, scientific discoveries, culture, the arts and daily life in Israel. He loves hiking the country with his family (and blogging about it). Originally from California, he lives in Jerusalem with his wife and three children.
.png)
No hay comentarios:
Publicar un comentario